Abstract
Flavocoxid is a mixed extract containing baicalin and catechin, and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activity in vitro. Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models. Inflammation and oxidative stress contribute in the pathogenesis of atherosclerosis. In the present study, an experimental rabbit model of hypercholesterolemia was developed and the effects of flavocoxid were evaluated. Rabbits were divided into four groups—normal control, high-cholesterol-diet (HCD)-fed group, HCD plus flavocoxid (20 mg/kg/day), or HCD plus atorvastatin (10 mg/kg/day). Blood samples were collected at the end of the experiment for measuring serum total cholesterol (TC), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), C-reactive protein (CRP), malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD). In addition, the aorta was removed for measurement of antioxidant status, vascular reactivity, and intima/media (I/M) ratio. Elevated levels of serum TC, TGs, LDL-C, and CRP were measured in HCD group. Moreover, HCD caused a significant increase in serum and aortic MDA concomitantly with a reduction in serum and aortic GSH and SOD. Immunohistochemical staining of aortic specimens from HCD-fed rabbits revealed high expression levels of both tumor necrosis factor-alpha (TNF-α) and nuclear factor (NF)-κB. Rabbits in flavocoxid group showed significantly lower levels of serum CRP, serum, and aortic MDA and higher levels of serum HDL-C, serum, and aortic GSH and SOD compared to HCD group. HCD-induced elevations in serum TC and LDL-C did not significantly affected by flavocoxid treatment. Additionally, flavocoxid significantly enhanced rabbit aortic endothelium-dependent relaxation to acetylcholine and decreased the elevated I/M ratio. This effect was confirmed by histopathological examination of the aorta. Moreover, flavocoxid effectively suppresses the release of inflammatory markers. In conclusion, these findings demonstrated that flavocoxid would be useful in preventing oxidative stress, inflammation, and vascular dysfunction induced by HCD.
References
Ahmed S, Gul S, Gul H, Zia-Ul-Haq M, Ercisli S (2014) Cyclooxygenase-2 inhibition improves antioxidative defense during experimental hypercholesterolemia. Bosn J Basic Med Sci 14:63–69
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475
Altavilla D, Squadrito F, Bitto A, Polito F, Burnett BP, Di Stefano V, Minutoli L (2009) Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol 157:1410–1418
Atmaca G (2004) Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 45:776–788
Bahorun T, Soobrattee MA, Luximon-Ramma V, Aruoma OI (2006) Free radicals and antioxidants in cardiovascular health and disease. IJMU 1:1–17
Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95:764–772
Bauer R (1999) Cyclooxygenase and 5-lipoxygenase as targets for medicinal plant research. In: Bohlin L, Bruhn JG (eds) Bioassay methods in natural product research and drug development. Kluwer Academic, Dortrecht/Boston, MA/London, pp. 128–132
Bitto A, Minutoli L, David A, Irrera N, Rinaldi M, Venuti FS, Squadrito F, Altavilla D (2012) Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit Care 16:R32
Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A (2007) Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci 81:121–127
Chappell SP, Lewis MJ, Henderson AH (1987) Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc Res 21:34–38
Chenevard R, Hurlimann D, Bechir M, Enseleit F, Spieker L, Hermann M (2003) Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107:405–409
Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633–12638
Collins T (1993) Endothelial nuclear factor kB and the initiation of atherosclerotic lesions. Lab Investig 68:499–508
De Winther MJP, Kanters E, Kraal G, Hofker MH (2005) Nuclear factor κB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25:904–914
Diaz MN, Frei B, Vita JA, Keaney Jr JF (1997) Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408–416
El-Awady MS, Suddek GM (2014) Agmatine ameliorates atherosclerosis progression and endothelial dysfunction in high cholesterol-fed rabbits. J Pharm Pharmacol 66:835–843
El-Bassossy HM, Hassan NA, Mahmoud MF, Fahmy A (2014) Baicalein protects against hypertension associated with diabetes: effect on vascular reactivity and stiffness. Phytomedicine 21:1742–1745
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
Finley PR, Schifman RB, Williams RJ, Lichti DA (1978) Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem 24:931–933
FitzGerald GA (2003) COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2:879–890
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins—an integrated approach to mechanisms and disorders. N Engl J Med 276:34–42
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Galle J, Busse R, Bassenge E (1991) Hypercholesterolemia and atherosclerosis change vascular reactivity in rabbits by different mechanisms. Arterioscler Thromb 11:1712–1718
Han J, Wang D, Yu B, Wang Y, Ren H, Zhang B, Wang Y, Zheng Q (2014) Cardioprotection against ischemia/reperfusion by licochalcone B in isolated rat hearts. Oxid Med Cell Longev 2014:134862
Hayashi T, Matsui-Hirai H, Fukatsu A, Sumi D, Kano-Hayashi H, Rani PJA, Iguchi A (2006) Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism. Atherosclerosis 187:316–324
Hou X, Han J, Yuan C, Ren H, Zhang Y, Zhang T, Xu L, Zheng Q, Chen W (2015). Cardioprotective effects of total flavonoids extracted from Xinjiang Sprig Rosa rugosa against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart. Cardiovasc Toxicol
Jayakody L, Senaratne M, Thomson A, Kappagoda T (1987) Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 60:251–264
Jeon SM, Park YB, Choi MS (2004) Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nutr 23:1025–1034
Krakauer T, Li BQ, Young HA (2001) The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Lett 500:52–55
Libby P (2007) Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65:S140–S146
Lin C, Ren J, Wang M, Ma X, Liu J (2011) Study of rongban tongmai granule on anti-oxidant stress in atherosclerosis. Zhongguo Zhong Yao Za Zhi 36:195–199
Marklund SL (1985) Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res 148:129–134
Messina S, Bitto A, Aguennouz M, Mazzeo A, Migliorato A, Polito F, Irrera N, Altavilla D, Vita GL, Russo M, Naro A, De Pasquale MG, Rizzuto E, Musarò A, Squadrito F, Vita G (2009) Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. Exp Neurol 220:349–358
Montagnana M, Danese E, Lippi G (2014) Genetic risk factors of atherothrombosis. Pol Arch Med Wewn 124:474–482
Montecucco F, Mach F (2008) New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging 3:341–349
Nam NH (2006) Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6:945–951
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Ondrejovičová I, Muchová J, Mišľanová C, Nagyová Z, Duračková Z (2010) Hypercholesterolemia, oxidative stress and gender dependence in children. Prague Med Rep 111:300–312
Oosterveer DM, Versmissen J, Yazdanpanah M, van der Net JB, Defesche JC, Kastelein JJ, Sijbrands EJ (2009) 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia. Atherosclerosis 206:223–227
Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM (1989) Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest 83:465–473
Park SH, Park JH, Kang JS, Kang YH (2003) Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 35:168–182
Paffen E, DeMaat MP (2006) C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71:30–39
Papageorgiou N, Tousoulis D, Katsargyris A, Charakida M, Androulakis E, Siasos G, Tentolouris C, Stefanadis C (2013) Antioxidant treatment and endothelial dysfunction: is it time for flavonoids? Recent Pat Cardiovasc Drug Discov 8:81–92
Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534
Polito F, Bitto A, Irrera N, Squadrito F, Fazzari C, Minutoli L, Altavilla D (2010) Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. Br J Pharmacol 161:1002–1011
Pronin AV, Danilov LL, Narovlyansky AN, Sanin AV (2014) Plant polyisoprenoids and control of cholesterol level. Arch Immunol Ther Exp 62:31–39
Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre-Salvayre A (2003) HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 17:743–745
Simonet S, Porro de Bailliencourt J, Descombes JJ, Mennecier P, Laubie M, Verbeuren TJ (1993) Hypoxia causes an abnormal contractile response in the atherosclerotic rabbit aorta: implication of reduced nitric oxide and cGMP production. Circ Res 72:616–630
Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol 142:317–327
Stocker R, Keaney Jr JF (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478
Verbeuren TJ, Bonhomme E, Laubie M, Simonet S (1993) Evidence for induction of non-endothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol 21:841–845
Wagner H (1993) Leading structures of plant origin for drug development. J Ethnopharmacol 38:105–112
Yokozawa T, Ishida A, Cho EJ, Nakagawa T (2003) The effects of coptidio rhizoma extract on a hypercholesterolemic animal model. Phytomedicine 10:17–22
Acknowledgments
The authors acknowledge Dr. Mohamed F. Hamed, Department of Pathology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt, for providing assistance.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Sheakh, A.R., Ghoneim, H.A., Suddek, G.M. et al. Antioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 388, 1333–1344 (2015). https://doi.org/10.1007/s00210-015-1168-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-015-1168-4